EUCTR2009-016371-30-BE进行中（未招募）不适用
International, multi-center, study of a twenty-eight week, open-label, titrated oral lixivaptan administration in patients with chronic hyponatremia: extension to studies CK-LX3401, 3405, and 3430 - Ole
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Men and women 18 years of age or older
- •2.Ability to provide informed consent or assent
- •3.Prior participation in a lixivaptan hyponatremia trial with evidence of continued need or desire for therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.A current medical condition where long-term treatment with an aquaretic agent may present an undue risk to the patient
- •2.Hyponatremia which is acute, reversible, artifactual or due to conditions not associated with vasopressin excess or likely to respond to aquaretic therapy
- •3.Hyponatremia due to reversible medical condition or therapy
- •4.Conditions associated with an independent imminent risk of morbidity and mortality
研究者
相似试验
进行中（未招募）
不适用
International, multi-center, study of a twenty-eight week, open-label, titrated oral lixivaptan administration in patients with chronic hyponatremia: extension to studies CK-LX3401, 3405, and 3430 - OleChronic hyponatraemiaMedDRA version: 12.1Level: LLTClassification code 10021036Term: HyponatraemiaEUCTR2009-016371-30-DECardiokine Biopharma LLC150
进行中（未招募）
不适用
International, multi-center, study of a twenty-eight week, open-label, titrated oral lixivaptan administration in patients with chronic hyponatremia: extension to studies CK-LX3401, 3405, and 3430 - OleChronic hyponatraemiaMedDRA version: 12.1Level: LLTClassification code 10021036Term: HyponatraemiaEUCTR2009-016371-30-CZCardiokine Biopharma LLC150
已完成
不适用
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430PER-068-10Cardiokine Biopharma, LLC,
已完成
3 期
International, Multicenter, Study of a Twenty-Eight Week,Open-Label, Titrated Oral Lixivaptan Administration inPatients with Chronic Hyponatremia: Extension to StudiesCK-LX3401, 3405, and 3430CTRI/2010/091/000335CARDIOKINE150
进行中（未招募）
1 期
A clinical study with many of countries and sites participating. This study wants to look into the relationship of the genotype IL28B in patients from all over the world which are suffering from an inflammation of the liver with hepatitis C virusEUCTR2011-001096-39-SKF.Hoffmann-La Roche Ltd.4,200